Cheshire, United Kingdom

Suzanne Saxon Bowker

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2008-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suzanne Saxon Bowker. Retrieved from https://idiyas.com/inventor/suzanne-saxon-bowker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 40(Granted Patents)


Location History:

  • Cheshire, GB (2008 - 2010)
  • Macclesfield, GB (2011)

Company Filing History:


Years Active: 2008-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Suzanne Saxon Bowker

Introduction

Suzanne Saxon Bowker, a notable inventor residing in Cheshire, GB, has made significant contributions to the field of medicinal chemistry. With a total of four patents to her name, Bowker is recognized for her innovative approaches to treating serious health conditions through her groundbreaking inventions.

Latest Patents

Among her latest patents, Bowker has developed compounds that affect glucokinase, specifically aimed at the treatment and prevention of type 2 diabetes. This invention entails a specific compound and its derivatives that may play a crucial role in managing patients’ conditions complicating glucokinase activity. Furthermore, she has also patented an oxadiazole derivative that serves as an inhibitor of DGAT enzymes. These compounds have potential implications in treating obesity, enhancing the spectrum of therapeutics available for these prevalent health issues.

Career Highlights

Bowker's career has been marked by her dedication to research and development within the pharmaceutical sector. Currently, she is employed at AstraZeneca, a prominent global biopharmaceutical company. Her work has not only led to valuable patent acquisitions, but it has also substantially advanced the scientific community’s understanding of certain diseases and their treatments.

Collaborations

Throughout her career, Bowker has collaborated with esteemed professionals, including her coworkers Scott Boyd and Peter William Rodney Caulkett. These partnerships exemplify the collaborative nature of innovation in the scientific community, where diverse expertise fosters significant advancements.

Conclusion

Suzanne Saxon Bowker represents the spirit of innovation in the pharmaceutical industry. Through her patent achievements and collaborative work, she continues to pave the way for new treatments that may alter the course of chronic diseases such as diabetes and obesity. Her contributions remind us of the critical role that inventors play in enhancing healthcare and improving the quality of life for many individuals around the globe.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…